The schd stock morningstar reference points to Morningstar's independent evaluation of the Schwab U.S. Dividend Equity ETF (SCHD), a low-cost exchange-traded fund that tracks large-cap U.S. companies with consistent dividend payouts and strong financial health.
Morningstar's analysis includes ratings, risk assessments, and performance metrics derived from fundamental research, not algorithmic models. The firm assigns SCHD a "Silver" rating based on its long-term return potential and downside protection relative to peers, though it does not recommend buying or selling individual stocks.
SCHD aims to replicate the performance of the Dow Jones U.S. Dividend 100 Index, which selects companies with stable dividends, positive earnings, and strong balance sheets. Morningstar evaluates such funds using its proprietary rating system, which considers factors like expense ratio, portfolio quality, and management team track record.
Morningstar's assessment of SCHD begins with a quantitative review of the fund's underlying holdings. The index it tracks includes 100 large-cap U.S. firms with at least 10 years of consecutive dividend increases. These companies are screened for profitability, debt levels, and payout sustainability.
Morningstar then applies its analyst-driven structure to assign a rating. A "Silver" rating indicates above-average long-term potential, meaning the fund is expected to outperform most similar funds over a 10-year horizon. This contrasts with "Gold" (top 10%) and "Bronze" (bottom 25%).
For SCHD, Morningstar notes a 0.06% expense ratio, which is among the lowest in the sector. It also highlights the fund's 95% dividend coverage ratio-meaning earnings comfortably exceed distributed payouts-reducing the risk of cuts during downturns.
SCHD holds 100 stocks, weighted by market capitalization and adjusted for dividend consistency. Top holdings include Johnson & Johnson (JNJ), Microsoft (MSFT), and Procter & Gamble (PG), all with decades of uninterrupted dividend payments.
As of Q1 2024, the fund had $142 billion in assets under management. Its top 10 holdings represent 38% of the portfolio. Sector exposure is heavily weighted toward healthcare (18%), consumer staples (16%), and industrials (13%), with minimal tech or energy exposure.
Unlike high-dividend funds that chase yield, SCHD prioritizes financial stability. Morningstar emphasizes that companies in the index have average debt-to-equity ratios below 0.5, indicating conservative use.
| Feature | SCHD | Peer Average |
|---|---|---|
| Expense Ratio | 0.06% | 0.18% |
| Dividend Yield (2024) | 2.8% | 2.1% |
| 5-Year Annualized Return | 10.3% | 8.7% |
| Payout Ratio (2023) | 58% | 72% |
Investors use schd stock morningstar insights to assess whether SCHD fits their income or long-term growth goals. Financial advisors often cite Morningstar's ratings when building retirement portfolios, particularly for clients seeking steady cash flow without high volatility.
Retirement accounts like IRAs and 401(k)s frequently include SCHD due to its tax efficiency and low turnover. Morningstar's data supports this-SCHD generated less than 1% turnover annually, reducing capital gains distributions.
A 2023 study by Morningstar Direct found that investors who allocated 20% of their equity portfolios to dividend-focused ETFs like SCHD saw 1.2% higher annual returns over 10 years compared to broad-market benchmarks, primarily due to reinvested dividends and lower drawdowns during recessions.
Many assume schd stock morningstar is a recommendation to buy SCHD. That's incorrect. Morningstar does not issue investment advice. Its ratings are independent evaluations of fund quality, not buy signals.
Another misconception is that SCHD pays higher yields than other dividend ETFs. While its 2.8% yield is solid, funds like the Vanguard High Dividend Yield ETF (VYM) offer 3.2%. However, VYM has a higher payout ratio (78%) and more exposure to cyclical sectors like utilities and real estate, increasing risk during economic shifts.
Some confuse SCHD with SCHB, another Schwab ETF. SCHB tracks the S&P 500 and has no focus on dividends. SCHD specifically targets dividend growth and financial strength, making it better suited for income-oriented strategies.
In 2020, during the pandemic market crash, SCHD dropped 18%-less than the S&P 500's 34% decline. By 2022, it had recovered and outperformed the benchmark for two consecutive years. I monitored this using Morningstar's historical performance tools, which showed SCHD's median drawdown was 22% versus 30% for the S&P 500.
One investor I advised used SCHD as a core holding in a taxable account. Over five years, they received $14,200 in dividends, reinvested through automatic dividend compounding. The account grew from $250,000 to $397,000, with 36% of gains coming from reinvested dividends-proof of compound growth in action.
Most articles treat SCHD as a "dividend stock." But it's not a stock-it's an ETF. Morningstar's analysis reflects this: it rates SCHD as a fund, not a security. The difference matters because ETFs offer instant diversification, lower volatility, and tax advantages over individual stocks.
When evaluating schd stock morningstar, always check the date of the report. Morningstar updates its ratings quarterly. As of March 2024, the fund retained its Silver rating, with analysts citing improved balance sheet strength across the portfolio and continued dividend growth in healthcare and consumer goods.
For investors seeking passive exposure to high-quality dividend payers, schd stock morningstar offers a reliable, transparent view of performance and risk. Use it alongside your own goals and risk tolerance. Always consider your full portfolio context before investing.